These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9396396)

  • 1. Serum tissue polypeptide antigen in bladder cancer as a tumor marker: a prospective study.
    Maulard-Durdux C; Toubert ME; Hennequin C; Housset M
    J Clin Oncol; 1997 Dec; 15(12):3446-50. PubMed ID: 9396396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study.
    Maulard C; Toubert ME; Chretien Y; Delanian S; Dufour B; Housset M
    Cancer; 1994 Jan; 73(2):394-8. PubMed ID: 8293406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of tissue polypeptide antigen in the follow-up of bladder cancer.
    Menéndez López V; Galán JA; Fernández-Suárez A; López-Celada S; Alcover J; Filella X
    Urology; 2003 Aug; 62(2):243-8. PubMed ID: 12893327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer.
    Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N
    Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients].
    Akiyama T; Tsujihashi H; Boku E; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T
    Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology.
    Bantis A; Zissimopoulos A; Sountoulides P; Giannakopoulos S; Kalaitzis C; Athanassiadou P; Agelonidou E; Touloupidis S
    Hell J Nucl Med; 2010; 13(3):213-7. PubMed ID: 21193872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratins as serum markers in egyptian bladder cancer. A comparison of CYFRA 21-1, TPA and TPS.
    Mady EA
    Int J Biol Markers; 2001; 16(2):130-5. PubMed ID: 11471896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma].
    Tizzani A; Casetta G; Cavallini A; Piana P; Piantino P
    Minerva Urol Nefrol; 1990; 42(2):69-71. PubMed ID: 2392743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
    Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
    Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder].
    Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Blanco Jimenez E; Hermida Gutiérrez J; Resel Estévez L
    Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of tissue polypeptide antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer.
    Hefler L; Tempfer C; Frischmuth K; Maenner G; Concin N; Sliutz G; Reinthaller A; Leodolter S; Kainz C
    Tumour Biol; 2000; 21(2):98-104. PubMed ID: 10686539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH; Lenk SV; Schlechte HH; Loening SA
    Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue polypeptide antigen and carcinoembryonic antigen lack diagnostic accuracy in urothelial carcinoma.
    Stefanović V; Mitić-Zlatković M; Ignjatović I; Vlajković M; Sćepović Z
    Int Urol Nephrol; 1999; 31(4):443-9. PubMed ID: 10668938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A basic and clinical evaluation of a new immunoradiometric assay kit for human serum tissue polypeptide antigen (TPA)].
    Shimojo K; Watanabe N; Sakai S; Kobayashi M; Ohtake H; Hatori N; Fukasawa K; Tomiyoshi K; Inoue T; Endo K
    Kaku Igaku; 1996 Jun; 33(6):655-61. PubMed ID: 8741511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: a follow-up study.
    Senatore S; Zizzi L; Blasi C; Alfieri G; Saccani Jotti G; Gabrielli M; Luccarelli S
    Oncology; 1990; 47(1):37-42. PubMed ID: 2300382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer.
    van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L
    Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.
    van der Gaast A; Kirkels WJ; Blijenberg BG; Splinter TA
    J Cancer Res Clin Oncol; 1992; 118(8):626-8. PubMed ID: 1517284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
    Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
    Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
    Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
    Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.
    Carbin BE; Ekman P; Eneroth P; Nilsson B
    Urol Res; 1989; 17(5):269-72. PubMed ID: 2815427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.